Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers develop new tool to better predict AML outcomes in older patients

General MRC MHU MRC WIMM Publication Research

In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.

Hydroxychloroquine provides moderate COVID-19 prevention

DTU

COPCOV, the world’s largest COVID-19 chemoprevention study, published results today showing that hydroxychloroquine (HCQ) has a moderate benefit in preventing COVID-19. The COPCOV trial was led globally by the Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand. The Diabetes Trials Unit (DTU) was the UK coordinating centre for the trial, helped develop the protocol, and was responsible for managing UK sites, approvals and procedures.

Patients receiving steroids are more than twice as likely to develop diabetes, UK study has found

DTU General OCDEM Research

Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment, a new study by researchers at the Radcliffe Department of Medicine’s Diabetes Trial Unit has found.

RDM researchers among world-leading cardiologists at ESC Congress 2024

CVM General Research

World-leading cardiology experts are to convene at the annual European Society of Cardiology (ESC) Congress in London from tomorrow (Friday 30 August).

Senior Fellowship awarded to Beth Psaila

General MRC MHU MRC WIMM

Congratulations to Beth Psaila, who has been awarded a Senior Fellowship funded by Cancer Research UK in partnership with Rosetrees Trust.

Michael Zimmermann awarded Full Professor title

Awards General

Congratulations to Professor Michael Zimmermann, who has been awarded the title of Full Professor in the University’s 2024 Recognition of Distinction exercise.

Of Mice and Men - Researchers demonstrate evolutionary conservation of blood stem cell subtypes

General MRC MHU MRC WIMM Publication Research

Researchers from the MRC Weatherall Institute of Molecular Medicine (WIMM) have shown that blood stem cell subtypes found in mice also exist in humans. This provides important information for research into therapies to alleviate the negative effects of aging.

RDM researchers showcase at IF Oxford 2024 – book now

IF Oxford returns as a digital and in-real-life science and ideas Festival with events running throughout October 2024.

Grant awarded to develop artificial intelligence tools to understand the bone marrow landscape

NDCLS Research

Our researchers have received $200,000 to develop artificial intelligence tools to better diagnose what goes wrong in the bone marrow of myeloproliferative neoplasm (MPN) patients.

Vote for AI research shortlisted for the BHF Research Story of the Year award

AMIIC CVM Research

Voting is open! Some of our British Heart Foundation funded research has been shortlisted for the BHF Research Story of the Year award. Discover more and vote for our work into developing an AI tool to predict people’s risk of having a heart attack years before it happens.

Qiang Zhang appointed Associate Professor of AI in Cardiovascular Imaging

CVM Research

RDM and the Big Data Institute have appointed Dr Qiang Zhang as Associate Professor of AI in Cardiovascular Imaging.

Experts outline priority areas which should be addressed to advance treatment for inherited lung diseases

General NDCLS Research

An expert group including Deborah Gill, Professor of Gene Medicine in RDM’s Nuffield Division of Clinical Laboratory Sciences, has published a new position paper which addresses the gaps in research and treatment development for familial pulmonary fibrosis (FPF) – a collection of individually rare and severe genetically inherited lung diseases.

Jeremy Tomlinson awarded Outstanding Chief Investigator in NIHR celebration

Awards General OCDEM

Congratulations to Professor Jeremy Tomlinson on winning an award for ‘Outstanding Chief Investigator’ from the National Institute of Health and Care Research’s (NIHR) Thames Valley and South Midlands Clinical Research Network (LCRN).

RDM Inaugural Lecture success for Professor Vanessa Ferreira

CVM General OCMR

On Monday 22 July, Professor Vanessa Ferreira gave her inaugural lecture titled, The investigation of cardiovascular diseases using MRI parametric mapping: The Past, Present and Future.

New study finds semaglutide (or ‘Ozempic/Wegovy’) safe for brain health with possible benefits for cognition and nicotine dependence

General Research

Semaglutide – widely known as Ozempic or Wegovy – does not appear to negatively impact brain health and is associated with lower risk of cognitive problems and less nicotine dependence, according to a new study.

Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies

General MRC MHU MRC WIMM Research

Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.

Senior Fellowship awarded to Costas Christodoulides

Awards General OCDEM

Congratulations to Costas Christodoulides, who has been awarded a Senior Clinical Research Fellowship with the British Heart Foundation.

Load More

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk